Population pharmacokinetics of peginterferon α2a in patients with chronic hepatitis B

Population pharmacokinetics of peginterferon α2a in patients with chronic hepatitis B

Abstract There were significant differences in response and pharmacokinetic characteristics to the peginterferon α2a treatment among Chronic Hepatitis B (CHB) patients. The aim of this study is to identify factors which could significantly impact the peginterferon α2a pharmacokinetic characteristics...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jingfeng Bi, Xingang Li, Jia Liu, Dawei Chen, Shuo Li, Jun Hou, Yuxia Zhou, Shanwei Zhu, Zhigang Zhao, Enqiang Qin, Zhenman Wei
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/7848e3114bac468c9b790b7a907200ea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares